Your browser doesn't support javascript.
loading
Montrer: 20 | 50 | 100
Résultats 1 - 1 de 1
Filtre
Ajouter des filtres








Gamme d'année
1.
Journal of the Korean Neurological Association ; : 372-375, 2019.
Article Dans Coréen | WPRIM | ID: wpr-766822

Résumé

Cefepime is a fourth-generation cephalosporin, developed in 1994, and is well known for its adverse effects. In 2002, the Food and Drug Administration adjusted the labeling to account for increased risk of seizures, encephalopathy and myoclonus, especially in the setting of renal impairment. Here we present a case of an 86-year-old female, undergoing Cefepime treatment, with encephalopathy mimicking acute stroke.


Sujets)
Sujet âgé de 80 ans ou plus , Femelle , Humains , Encéphalopathies , Myoclonie , Crises épileptiques , Accident vasculaire cérébral , Food and Drug Administration (USA)
SÉLECTION CITATIONS
Détails de la recherche